Chemed Corporation (CHE) Tops Q4 EPS by 5c, Beats on Revenue
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $436.27 --0%
EPS Growth %: +31.9%
Financial Fact:
Service revenues and sales: 392.61M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +31.9%
Financial Fact:
Service revenues and sales: 392.61M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Chemed Corporation (NYSE: CHE) reported Q4 EPS of $6.83, $0.05 better than the analyst estimate of $6.78. Revenue for the quarter came in at $640 million versus the consensus estimate of $636.1 million.
For earnings history and earnings-related data on Chemed Corporation (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- H.C. Wainwright Reiterates Buy Rating on Elicio Therapeutics (ELTX)
- H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
